Ho et al. demonstrated that siRNA-mediated UBE2S knockdown inhibited the metastasis of NSCLC in vivo, which was related to the inhibition of the nuclear factor kappa B signaling pathway [58]. Here, UBE2S is linked to non-small cell lung carcinoma.